LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

VAISHALI

NSE
Vaishali Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE972X01022
ENहिन्दीગુજરાતીमराठी
7.70
0.01 (-0.13%)
20/4/2026, 10:29:40 pm
NSE
7.70
0.01
-0.13%
579111305-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open7.88
High7.95
Low7.51
Prev Close7.71
Volume13.05Cr
Value
L: 7.51H: 7.95
52 WEEK
Low4.75
High15.24
28% of 52W range
Info
Face Value₹2
Listed2020-01-15
ISININE972X01022
SeriesEQ

Key Metrics

1D
-4.28%
1W
-8.32%
1M
+32.17%
3M
-13.04%
6M
-25.71%
Valuation
Mkt Cap₹80 Cr
Growth (QoQ)
Revenue+34.30%
PAT-26.71%
EPS+549.01%
TTM Revenue
₹99 Cr
TTM EBITDA
₹91,56,000
TTM PAT
₹42,73,000
TTM EPS
₹0.84
Rev/Share
₹7.6

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr8 Cr16 Cr24 Cr32 Cr23-0323-0623-0923-1224-0324-0624-0924-120.00.20.20.2-0.40.10.21.0
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-3128 Cr27 Cr2 Cr2 Cr1 Cr0.98
2024-09-3021 Cr19 Cr3 Cr3 Cr2 Cr0.15
2024-06-3018 Cr16 Cr2 Cr2 Cr2 Cr0.15
2024-03-3132 Cr40 Cr-6 Cr-6 Cr-5 Cr-0.44
2023-12-3128 Cr26 Cr3 Cr3 Cr2 Cr0.20
2023-09-3013 Cr11 Cr2 Cr2 Cr2 Cr0.16
2023-06-3013 Cr12 Cr2 Cr2 Cr2 Cr0.15
2023-03-3126 Cr26 Cr1 Cr1 Cr0 Cr0.04

Shareholding Pattern

CURRENT2026-03-31
31.6%PROMOTER
Promoter31.6%
Public68.4%
PROMOTER HOLDING TREND
26.3%24-0926.3%24-1226.3%25-0326.3%25-0931.6%25-1231.6%25-1231.6%26-03

Corporate Actions

Ex-DateTypePurpose
2024-10-15SplitFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
2024-10-15BonusBonus 1:1
2024-09-19OtherAnnual General Meeting
2023-09-22OtherAnnual General Meeting
2022-12-27OtherExtra Ordinary General Meeting
2022-09-23OtherAnnual General Meeting
2021-09-22Other Annual General Meeting
2021-07-28Other Extra Ordinary General Meeting
2020-09-22Other Annual General Meeting

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-04-307.958.057.557.611.43L
2026-04-298.008.257.927.9461,011
2026-04-288.198.287.908.0562,349
2026-04-278.068.397.848.121.01L
2026-04-247.928.437.888.031.98L
2026-04-238.618.758.208.294.19L
2026-04-229.229.278.708.808.12L
2026-04-217.859.307.849.0733.78L
2026-04-207.887.957.517.753.53L
2026-04-176.687.866.637.7114.28L
2026-04-166.806.836.546.552.95L
2026-04-156.786.906.536.674.38L
2026-04-136.196.845.936.497.76L
2026-04-106.306.546.026.116.20L
2026-04-096.276.316.096.181.15L
2026-04-086.236.346.156.172.89L
2026-04-076.356.355.895.952.50L
2026-04-025.806.175.325.983.62L
2026-04-015.005.855.005.855.62L
2026-03-275.715.835.065.183.80L
2026-03-255.755.995.605.734.26L
2026-03-246.126.125.675.751.73L
2026-03-205.986.275.945.9899,658
2026-03-196.106.105.725.9870,424
2026-03-186.206.205.676.131.47L
2026-03-176.106.285.986.071.00L
2026-03-166.406.405.885.992.36L
2026-03-136.486.486.026.122.14L
2026-03-126.706.746.206.332.72L
2026-03-116.766.766.476.501.47L

Frequently Asked Questions

About

Vaishali Pharma Limited is an Indian company engaged in the marketing of a diverse range of veterinary and healthcare pharmaceutical products, including active pharmaceutical ingredients, formulations, surgical items, supplements, and nutraceuticals. The company has a market capitalization of approximately ₹1.0 billion and focuses on providing healthy healthcare solutions globally.

BOARD OF DIRECTORS